MALVERN, Pa. - Annovis Bio Inc. (NYSE: ANVS), a clinical-stage drug platform company trading near its 52-week low of $2.99, has announced the initiation of a Phase 3 trial for its Alzheimer's disease ...

A high drug failure rate is more than just a pattern recognition problem. Here's how we can address some of the root causes.

Kohl’s Closing 27 Stores Across The US Including In PA FDA Approves ZYN Nicotine Pouches For Sale, Restricts Ads Targeting Teens Philly Teacher Who Made Threats To NJ Principal Placed On Leave For ...

Although anatomic imaging will remain important, molecular imaging provides several new opportunities to make the process of drug development more efficient. Various techniques for molecular ...

Across drug discovery and development, as well as in healthcare delivery, artificial intelligence (AI) is becoming increasingly widespread and empowering, and 2025 will see regulations on its ...

(Reuters) -U.S. drugmaker Pfizer is going "all in" to develop its experimental obesity drug and has been recruiting more experts in that area, Chief Executive Officer Albert Bourla said at the ...

However, EPCT operations suffer from numerous inefficiencies, such as cumbersome start-up processes, which are particularly critical when drug safety and the recommended ... Group Beta (Inst), Janssen ...

Harry Sumnall receives funding from public grant awarding bodies for alcohol and other drugs research, and fees from (international) not-for-profit organisations and government departments for ...

Police have identified the individuals involved in the fatal gunfight at a short-term rental home in Long Pond, Pennsylvania, and uncovered evidence linking them to a Venezuelan drug ring, authorities ...

Pfizer is testing multiple doses of once-a-day version of its weight-loss pill, after scrapping development of a twice-daily version of the drug in late 2023. "At this point, I'm very cautious ...

Some of the drugs were bound for Malvern, video footage reveals. Mudhar bragged: "Business will never go down. How many times do you think we've been nicked? We've got brothers. We've got cousins.

NXP800 has been granted designations from the US Food and Drug Administration (FDA) to speed up its development to potentially treat ARID1a-deficient ovarian, fallopian tube, and peritoneal cancers, ...